Austria Patent System

AVL List GmbH (Graz, Austria) is the world's largest independent company for the development, simulation, and testing of powertrain systems — internal combustion engines, hybrid systems, electric drives, and fuel cell systems. AVL is majority-owned by the Kolbenschmidt Foundation (Stuttgart) and is the preeminent example of Austrian industrial patent activity. AVL IP highlights: (1) Powertrain test systems: AVL invented the modern chassis dynamometer and engine test bed systems used by virtually every major automotive manufacturer to develop and validate engines and powertrains. Patents cover: test bed mechanical design (force measurement, inertia simulation); test automation software (PUMA Open, IndiCom); combustion analysis hardware and software (AVL IndiSmart — engine combustion analyzer); emission measurement systems (AVL Emission Test Systems — AETs); real-driving emissions (RDE) test equipment; (2) Electrified powertrain development: as the auto industry transitions to EVs and hybrids, AVL has developed significant patent portfolios in: battery test systems (thermal management during charge/discharge cycles); e-motor testing; hydrogen fuel cell system testing (full stack and individual cell testing); range extender systems; (3) Software and simulation: AVL CRUISE (vehicle system simulation), AVL FIRE (CFD combustion simulation), AVL EXCITE (powertrain dynamics simulation) — simulation software patents and trade secrets protect AVL's competitive position; (4) Other Austrian automotive IP: Magna International (Canadian company but large Austrian operations in Graz — manufacturing of vehicles [Magna Steyr: BMW, Mercedes, Jaguar contract manufacturing] + automotive component patents); Anton Paar (Graz — precision laboratory instruments; viscosity/density measurement patents); HOERBIGER (Vienna — motion control and compressor components, automotive patents).

Austria has a significant chemicals and materials IP ecosystem anchored by BOREALIS AG and supported by Lenzing AG's fiber innovations. BOREALIS (Vienna, Austria/Abu Dhabi National Energy Company TAQA — headquartered in Vienna): BOREALIS is one of Europe's leading producers of polyolefins (polypropylene and polyethylene) and base chemicals, and holds an extensive polymer chemistry patent portfolio. Key BOREALIS IP areas: (1) Borstar technology: BOREALIS's proprietary Borstar bimodal polymerization process (patented EP and international portfolio) enables production of polyethylene and polypropylene with bimodal molecular weight distribution — giving superior mechanical properties (impact resistance + stiffness simultaneously) compared to conventional monomodal polyolefins. Borstar is licensed to operators worldwide; (2) Polyolefin applications patents: pressure pipe applications (PE100 — for water/gas distribution pipes; PE100-RC for demanding applications); cable insulation materials (specially formulated polyolefin compounds for power cables — critical for offshore wind power transmission cables); automotive lightweight applications (polypropylene compounds replacing metal components); (3) Catalyst technology: BOREALIS has developed proprietary metallocene catalysts and Ziegler-Natta catalyst systems for olefin polymerization — catalyst patents are the foundational IP protecting the Borstar process; (4) Lenzing AG (Lenzing, Upper Austria — cellulose fibers; TENCEL brand Lyocell and Modal fibers — patented lyocell spinning process using N-Methylmorpholine N-oxide [NMMO] solvent — licensed globally; Tencel fibers used in textiles, nonwovens, and specialty applications; Lenzing holds a strong position in sustainable fiber IP); (5) Frequentis AG (Vienna — voice communication systems for air traffic control, public safety, rail; listed on Vienna Stock Exchange; patents in ATC voice system design, digital voice switching, military communication); Anton Paar GmbH (scientific instruments; density meters, viscometers, rheometers — patents covering precision measurement methods used in pharma QC and industrial applications).

The UPC Central Division sub-section in Vienna handles revocation actions and declarations of non-infringement for Unitary Patents and European patents (with unitary effect) classified under IPC Section C — Chemistry and Metallurgy. This includes all chemistry-based patent technology, which specifically encompasses: pharmaceutical compounds and formulations; biotechnology inventions (DNA sequences, proteins, cell cultures); chemical processes and reactions; polymers and materials chemistry; metal alloys and metallurgical processes; fertilizers and agricultural chemicals; explosives; and paints, coatings, and adhesives. Why Vienna for chemistry/pharma: The original UPC Agreement designated Vienna for Section C for several reasons — Austria's historical strengths in pharmaceutical and chemistry patent examination at the APO and EPO Vienna branch; Vienna's status as a neutral European city and established international arbitration centre; the proximity of the EPO's Vienna office (making technical and legal expertise readily available); and Austria's position as a geographically central EU member state between the major Northern and Southern European IP hubs. Significance for the pharmaceutical industry: pharmaceutical companies are among the most active patent litigants in Europe. A generic drug manufacturer seeking to clear the way for market entry by invalidating an originator's Unitary Patent for a pharmaceutical compound files that revocation action at the Vienna sub-section. Originator companies defending their pharmaceutical Unitary Patents against revocation face Vienna Central Division proceedings. The Vienna sub-section's decisions on Unitary Patent validity will set precedents applicable across all 18+ UPC participating EU member states simultaneously — making individual Vienna revocation decisions potentially worth hundreds of millions of euros in pharmaceutical market impact.

The Austrian utility model (Gebrauchsmuster) is a registered IP right under the Gebrauchsmustergesetz (Utility Model Act, BGBl. Nr. 211/1994), providing 10 years of protection for certain inventions at a lower inventive step threshold and without substantive examination. Key features: (1) What can be protected: the Austrian Gebrauchsmuster can protect products — devices, apparatus, tools, instruments, and other physical products. CRITICALLY, it CANNOT protect processes or methods — this is a major limitation compared to Austria's invention patent system (which covers both products and processes). A new manufacturing process, a novel synthesis method, or a software algorithm cannot be registered as an Austrian utility model; (2) No substantive examination: the APO registers a Gebrauchsmuster after a formal examination only — it checks whether the application meets formal requirements (correct form, fees paid, proper description) but does NOT conduct a prior art search or evaluate whether the invention is novel, has the required inventive step, or is industrially applicable. This means a Gebrauchsmuster is granted faster and cheaper than an invention patent but is more vulnerable to validity challenges in enforcement proceedings; (3) Inventive step threshold: the utility model requires novelty and industrial applicability, but the inventive step threshold is lower than for an invention patent. In Austria, the utility model requires that the invention 'must not be obvious from the state of the art to a person skilled in the art' — but the obviousness assessment is less demanding than for a full patent; (4) 10-year term: the Gebrauchsmuster is renewable in 2-year increments from the initial 4-year registration to reach the maximum 10-year term; (5) Strategic use: Austrian Gebrauchsmuster are useful for product inventions where speed of protection matters (registered in 6–12 months), where the invention may not clear the full patent inventive step bar, or where cost is a constraint. Technology hardware companies, mechanical device companies, and consumer product manufacturers use Gebrauchsmuster for product-specific incremental improvements.

The EPO's Vienna branch is the largest branch office of the European Patent Office (outside the EPO's Munich headquarters), employing several hundred European patent examiners. The EPO's Vienna branch focuses primarily on chemistry, pharmaceuticals, biotechnology, and related technical fields — consistent with the broader international classification of technical areas assigned to Vienna. Historical context: The EPO established its Vienna branch when Austria acceded to the EPC in 1979. Prior to Austria's EPC accession, the Austrian Patent Office (APO) had already built significant patent search expertise, particularly in chemistry and related fields. The EPO incorporated this expertise by locating chemistry and pharma examination departments in Vienna. PCT cooperation: the Vienna EPO branch has been involved in PCT international search and preliminary examination work. Austria's APO has been designated as an International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA) under the PCT, working in cooperation with the EPO. PCT applicants who file through the EPO ISA (the most common route for European applicants) may have their applications searched by examiners based in the Vienna branch depending on the technical field. Alignment with UPC: the EPO's chemistry examination expertise in Vienna creates an important synergy with the UPC Central Division Vienna sub-section's chemistry/pharma revocation jurisdiction — both are drawing on the same pool of highly specialized European technical patent expertise in Vienna. This geographic concentration of chemistry patent expertise (EPO examination + UPC adjudication + APO national examination) makes Vienna a uniquely important city in the European pharmaceutical and chemistry IP ecosystem.

Austrian employee invention law is governed by the Arbeitnehmererfindungsgesetz (Employee Inventions Act, BGBl. Nr. 259/1969, as amended), which creates a structured framework allocating rights between employers and employees while requiring fair compensation. The Austrian framework: (1) Service inventions (Diensterfindungen): inventions made by employees that relate to the employer's business operations or that arose from the employee's activities at work. These are NOT automatically owned by the employer in Austria — the employer must actively claim them; (2) The employer's claim procedure: when an employee makes a service-related invention and discloses it to the employer in writing, the employer has 4 months to either claim the invention in full (Inanspruchnahme — full assignment), claim a non-exclusive license only, or release the invention to the employee. Failure to respond within 4 months results in the employer losing all rights to the invention — it becomes the employee's free invention. This 4-month window is a critical procedural step that Austrian companies must manage carefully; (3) Vergütung (remuneration): when an employer claims a service invention, the employee is entitled to equitable remuneration (Vergütung) — the amount is determined based on the invention's commercial value, the role of the employer's resources in creating it, and the employee's duties. The right to Vergütung is mandatory and cannot be waived in advance by contract; (4) Free inventions: inventions that are clearly outside the scope of the employer's business or the employee's work duties belong entirely to the employee — but the employee must notify the employer before filing; (5) Practical compliance: Austrian companies with R&D employees should maintain written invention disclosure procedures, track the 4-month response deadline, and have established policies for evaluating and compensating service inventions. The Arbeitnehmererfindungsgesetz is enforced and compensation disputes can reach Austrian labor courts.

Austria follows the EPC's absolute novelty standard — there is NO general grace period for Austrian national patents or for European patents validated in Austria. Any public disclosure before the patent application filing date destroys novelty permanently, with only a very narrow exception. The EPC Art. 55 exception: A disclosure is not taken into account as prior art if it occurred within 6 months before the filing date AND was due to: (a) an evident abuse in relation to the applicant or predecessor in title, OR (b) the fact that the applicant or predecessor in title displayed the invention at an officially recognized international exhibition falling within the terms of the Convention on International Exhibitions (Paris, November 22, 1928). In practice, this exception covers only a very specific category of world's fair/international exposition events — not ordinary trade shows, academic conferences, industry conferences, or commercial product launches. A publication in a journal, a presentation at a scientific conference, a product launch announcement, a pitch deck shown to investors, or a social media post describing the invention — any of these occurring before the Austrian (or EP) filing date will permanently destroy novelty for Austrian and European patent purposes. This is a critical difference from the US AIA grace period (12 months, covering any own disclosure of any kind): US inventors who have published or presented their work publicly can still file a valid US patent application within 12 months of that disclosure. The same disclosure would have permanently destroyed Austrian/European patent rights if no patent application was filed before the disclosure. For companies or inventors seeking both US and Austrian/European patent protection: file all patent applications BEFORE any public disclosure. The US grace period provides a safety net in the US, but offers no protection for international patent rights.